REGULATED PRESS RELEASE published on 05/06/2025 at 17:45, 1 year 6 months ago AXA - Indicateurs d'activité T1 2025
REGULATED PRESS RELEASE published on 05/06/2025 at 17:45, 1 year 6 months ago AXA - 1Q25 Activity Indicators AXA reports strong 1Q25 performance with 7% increase in gross written premiums to Euro 37.0 billion. Solvency II ratio at 213%. CFO Alban de Mailly Nesle optimistic about growth strategy execution Growth Strategy AXA Solvency II Ratio Premiums 1Q25
BRIEF published on 04/11/2025 at 18:05, 1 year 6 months ago AXA : Mise à jour sur le capital social et les droits de vote Droits De Vote Capital Social AXA Transparence Déclaration De Seuil
BRIEF published on 04/11/2025 at 18:05, 1 year 6 months ago AXA Discloses Voting Rights and Share Capital Data for March 2025 Euronext Paris Share Capital Voting Rights AXA Threshold Disclosure
REGULATED PRESS RELEASE published on 04/11/2025 at 18:00, 1 year 6 months ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/03/2025 AXA publie les informations sur le nombre total d'actions et de droits de vote en conformité avec la réglementation financière Déclaration Droits De Vote Capital Social AXA Financière
REGULATED PRESS RELEASE published on 04/11/2025 at 18:00, 1 year 6 months ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/03/2025 AXA, a French public company, discloses total shares and voting rights as of March 31, 2025, as required by French Commercial Code and AMF regulations Voting Rights Shares AXA AMF Regulations French Public Company
BRIEF published on 03/21/2025 at 17:56, 1 year 7 months ago AXA : Informations sur l'Assemblée Générale du 24 avril 2025 Assemblée Générale Transparence Documents Disponibles Actionnaires AXA Salle Pleyel
BRIEF published on 03/21/2025 at 17:56, 1 year 7 months ago AXA Announces Shareholders' Meeting Details for April 2025 Corporate Governance Investor Information Paris Event AXA Shareholders' Meeting April 24, 2025
REGULATED PRESS RELEASE published on 03/21/2025 at 17:51, 1 year 7 months ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 24 avril 2025 L'Assemblée Générale Mixte des actionnaires d’AXA se tiendra le 24 avril 2025 à Paris. Consultez les informations sur le site internet d’AXA. Renseignements et documents disponibles au siège social Actionnaires AXA Assemblée Générale Consultation Information
REGULATED PRESS RELEASE published on 03/21/2025 at 17:51, 1 year 7 months ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 24, 2025 AXA's Ordinary and Extraordinary Shareholders' Meeting of April 24, 2025 details the availability of information, including agenda, resolutions, and participation rules, on AXA's website AXA Shareholders' Meeting AGM Shareholder Rights Information
Published on 11/06/2026 at 22:15, 2 days 11 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 20 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 20 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 20 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/09/2026 at 09:00, 24 minutes ago Cantourage further develops Telecan and strengthens digital access to medical care
Published on 11/09/2026 at 09:00, 25 minutes ago Municipality Finance issues a GBP 50 million tap under its MTN programme
Published on 11/09/2026 at 09:00, 25 minutes ago Municipality Finance issues EUR 47.5 million zero coupon notes under its MTN programme
Published on 11/09/2026 at 09:00, 25 minutes ago Original-Research: EBRO MOTORS GROUP EV SA (von NuWays AG): BUY
Published on 11/09/2026 at 07:00, 2 hours 25 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 2 hours 25 minutes ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 2 hours 25 minutes ago Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
Published on 11/09/2026 at 07:00, 2 hours 25 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus
Published on 11/06/2026 at 19:06, 2 days 14 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026